Literature DB >> 8178779

Cigarette smoking and risk of fatal breast cancer.

E E Calle1, H L Miracle-McMahill, M J Thun, C W Heath.   

Abstract

The authors examined the association of fatal breast cancer and cigarette smoking in a large, prospective mortality study of US adults. After 6 years of follow-up, 880 cases of fatal breast cancer were observed in a cohort of 604,412 women who were cancer-free at interview in 1982. Cox proportional hazards modeling, adjusted for other risk factors, found that current smoking was significantly related to fatal breast cancer risk (adjusted rate ratio (RR) = 1.26, 95% confidence interval (CI) 1.05-1.50). A negative association was observed for former smokers, but this was not statistically significant (RR = 0.85, 95% CI 0.70-1.03). The association of current smoking with fatal breast cancer risk increased with increasing numbers of cigarettes per day and with total number of years smoked. For smokers of 40 or more cigarettes per day, the rate ratio was 1.74 (95% CI 1.15-2.62). The authors hypothesize that these results may be due to either a poorer prognosis among breast cancer cases who smoke or a delayed diagnosis among current smokers who do not receive mammograms as often as never or former smokers. Women who smoke should be targeted for breast cancer screening services.

Entities:  

Mesh:

Year:  1994        PMID: 8178779     DOI: 10.1093/oxfordjournals.aje.a116939

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  23 in total

1.  Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.

Authors: 
Journal:  Breast Cancer Res Treat       Date:  2007-10-31       Impact factor: 4.872

2.  Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project.

Authors:  John P Pierce; Ruth E Patterson; Carolyn M Senger; Shirley W Flatt; Bette J Caan; Loki Natarajan; Sarah J Nechuta; Elizabeth M Poole; Xiao-Ou Shu; Wendy Y Chen
Journal:  J Natl Cancer Inst       Date:  2013-12-07       Impact factor: 13.506

Review 3.  The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Authors:  Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

4.  Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output.

Authors:  M E Miller; A C Holloway; W G Foster
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 5.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

6.  Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.

Authors:  Keelia Rhoads; James C Sacco; Nicholas Drescher; Amos Wong; Lauren A Trepanier
Journal:  Toxicol Sci       Date:  2011-03-29       Impact factor: 4.849

Review 7.  Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.

Authors:  Dejana Braithwaite; Monika Izano; Dan H Moore; Marilyn L Kwan; Martin C Tammemagi; Robert A Hiatt; Karla Kerlikowske; Candyce H Kroenke; Carol Sweeney; Laurel Habel; Adrienne Castillo; Erin Weltzien; Bette Caan
Journal:  Breast Cancer Res Treat       Date:  2012-09-29       Impact factor: 4.872

Review 8.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

9.  Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Esther M John; Anna R Giuliano; Lisa M Hines; Shesh N Rai; Elizabeth C Riley; Christina M Pinkston; Roger K Wolff; Martha L Slattery
Journal:  Ann Epidemiol       Date:  2015-08-28       Impact factor: 3.797

10.  Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer.

Authors:  Patrick G Morris; Xi Kathy Zhou; Ginger L Milne; Daniel Goldstein; Laura C Hawks; Chau T Dang; Shanu Modi; Monica N Fornier; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.